Endpoints News and Financial Times journalists discuss the downfall of FDA Commissioner Marty Makary, live in New York at the FT's biotech and pharma summit.
Marty Makary resigned as FDA commissioner on Tuesday after a turbulent tenure at the head of the agency. Makary was scheduled to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Confirm Endpoints as a trusted biopharma news source
Bioscience & Technology Business Center
The University of Kansas
Marty Makary’s Turbulent Tenure at FDA Comes to an End
Why Marty Makary was the worst FDA commissioner in 25 years
After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report
Opinion | A desperately needed reset at the FDA
FDA chief Marty Makary resigns from agency, ending tumultuous tenure
Opinion | Here's How FDA Employees Learned Their Boss Was Really Gone
Makary departs FDA amid turmoil as Diamantas, agency's top food official, steps in
Here's What Stakeholders Want From the Next FDA Commissioner
Makary keeps working amid questions over his FDA future
FDA Commissioner Marty Makary Resigns
